Chief Executive Officer

• Jul 2022 - Present

In Transition

• Apr 2022 - Jun 2022

General Manager Europe-Founder, Executive Board Director

• Aug 2021 - Mar 2022

CNX Therapeutics Ltd is a Specialty, European Pharmaceutical Company dedicated to the treatment of CNS disorders. In August 2021 Inflexion Private Equity Partners LLP, a global investment firm, acquired the European subsidiary (now known as CNX Therapeutics Ltd) of a leading global CNS focused pharmaceutical company. Executive member of Board of Directors for CNX Therapeutics from point of transaction in August 2021. Ongoing (to 31st March 2022) Led the process to successfully "carve out" CNX Therapeutics, a 6-month process (from August 2021) from the parent company working closely with local team, providers, partners and previous parent company. Worked with new CNX Therapeutics Board of Directors, to ensure that strategic, and financial objectives were met in line with transaction expectations (which they were), to deliver a highly profitable business going forwards. Likewise that the current CNX Therapeutics team were line-managed and led/supported effectively though-out the transition process. They are a great team so this part of the process was a privilege and a pleasure. Ensured that the highest standards of GXP/legal compliance were maintained through the transition process to set the company up for success going forwards. Led the process to communicate the new Vision, Mission and corporate identity, to potential pharma partners/investors (UK, Europe and Global) and establish a strong pipeline of potential licencing/M&A opportunities for the future management to capitalise on. Left the Company following handover to new management and completion of transition process as planned at the end of financial year 31st March 2022.

General Manager Europe (Reporting to USA based Board of Directors)

• Oct 2016 - Aug 2021

Leadership & General Management of all functions for the European operation.Responsible for Europe, Russia, MENA, reporting to USA/Japan.Pricing and reimbursement responsibility across all markets, either directly or via partners.European build out to establish operations in Netherlands, Nordics, Switzerland to launch CNS asset.Out-licencing activity to secure partners in Italy, Spain, E Europe, Russia, CIS and MENA for CNS asset.Led the process to spin out the Sunovion Pharmaceuticals Europe business in 2021, with a Private Equity Investor to create CNX Therapeutics, launched in 2021

Country Manager UK (Reporting to USA based Board of Directors)

• Sep 2014 - Oct 2016

Leadership and General Management of all functions for the UK operation.Built, and led the UK affiliate and team to launch a CNS asset.

Global Marketing Director-Specialty Pharmaceuticals

• Aug 2013 - Aug 2014

Responsible for leading a team of international marketers managing a portfolio of Specialty Pharmaceuticals. Therapy areas include Oncology, Transplant, Infection and HIV and portfolio includes several Orphan drugs. Clinigen Group plc is a fast-growing specialty global pharmaceuticals and services business, dedicated to serving patients, the medical community and the healthcare industry to supply critical life-saving treatment. With offices in the UK, US and Japan, Clinigen is focused on delivering the right drug to the right patient at the right time.

Commercial Director

• Apr 2010 - Dec 2012

UK Head of Sales, Marketing & local Market Access of a team of 100+

Secondary Care Business Director

• May 2008 - Mar 2010

Head of Sales & Marketing: Secondary Care Business UnitLaunch of cardiovascular brand

Brand Leader: UK/Europe

• Feb 2007 - Apr 2008

Marketing Leadership role embedded within the European team to support European launch of Cardiovascular Brand.Worked at a European Level to support affiliate team across both companies to prepare for launch.

Sales Director-North

• Oct 2005 - Jan 2008

Member of UK Leadership Team.Functional Leadership of a sales force of 70 (Primary & Secondary Care, NHS Development).

Regional Business Director-North

• Jan 2004 - Sep 2005

Second Line Management role.Leadership of a sales force of 70 (Primary & Secondary Care, NHS Development)

National Operations Director

• Sep 2003 - Dec 2003

Consultant hired by new Managing Director to design and implement major organisational change Consultant hired by new Managing Director to design and implement major organisational change

District Sales Manager

• Sep 2001 - Aug 2003

Managed a team of 11 primary care and hospital representatives (South East) Managed a team of 11 primary care and hospital representatives (South East)

Regional Business Manager

• Sep 1998 - Aug 2001

Line Managed team of 7 representatives covering primary, secondary care and payers covering 1/3 of UK (south).

Medical Representative

• Jan 1997 - Aug 1998

Sales position covering primary care, pharmacy, secondary care and payers in NW England